Promius Pharma, LLC - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Promius Pharma, LLC - Product Pipeline Review - 2016', provides an overview of the Promius Pharma, LLC's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Promius Pharma, LLC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Promius Pharma, LLC - The report provides overview of Promius Pharma, LLC including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Promius Pharma, LLC's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Promius Pharma, LLC's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate Promius Pharma, LLC's strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Promius Pharma, LLC - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Promius Pharma, LLC's pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents
Table of Contents 2 List of Tables 5 List of Figures 5 Promius Pharma, LLC Snapshot 6 Promius Pharma, LLC Overview 6 Key Information 6 Key Facts 6 Promius Pharma, LLC - Research and Development Overview 7 Key Therapeutic Areas 7 Promius Pharma, LLC - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Promius Pharma, LLC - Pipeline Products Glance 12 Promius Pharma, LLC - Late Stage Pipeline Products 12 Pre-Registration Products/Combination Treatment Modalities 12 Phase III Products/Combination Treatment Modalities 13 Promius Pharma, LLC - Clinical Stage Pipeline Products 14 Phase II Products/Combination Treatment Modalities 14 Phase I Products/Combination Treatment Modalities 15 Promius Pharma, LLC - Early Stage Pipeline Products 16 Preclinical Products/Combination Treatment Modalities 16 Promius Pharma, LLC - Drug Profiles 17 DFD-01 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 DFN-11 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 tetracycline MR 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 DFD-06 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 DFD-10 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 DFN-02 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 ACT-01 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 celecoxib 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 DFN-10 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 DFN-15 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 DFN-14 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 DFN-19 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 DFD-04 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 DFD-05 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 DFD-08 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 Small Molecules 1 for Epilepsy 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 Small Molecules 1 for Parkinson's Disease 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 Small Molecules 2 for Epilepsy 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 Small Molecules 2 for Parkinson's Disease 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 Small Molecules 3 for Epilepsy 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 Small Molecules 3 for Parkinson's Disease 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 Small Molecules 4 for Epilepsy 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 Small Molecules 4 for Parkinson's Disease 39 Product Description 39 Mechanism of Action 39 R&D Progress 39 Promius Pharma, LLC - Pipeline Analysis 40 Promius Pharma, LLC - Pipeline Products by Target 40 Promius Pharma, LLC - Pipeline Products by Route of Administration 41 Promius Pharma, LLC - Pipeline Products by Molecule Type 42 Promius Pharma, LLC - Pipeline Products by Mechanism of Action 43 Promius Pharma, LLC - Recent Pipeline Updates 44 Promius Pharma, LLC - Dormant Projects 45 Promius Pharma, LLC - Locations And Subsidiaries 46 Head Office 46 Appendix 47 Methodology 47 Coverage 47 Secondary Research 47 Primary Research 47 Expert Panel Validation 47 Contact Us 47 Disclaimer 48
List of Tables
Promius Pharma, LLC, Key Information 6 Promius Pharma, LLC, Key Facts 6 Promius Pharma, LLC - Pipeline by Indication, 2016 8 Promius Pharma, LLC - Pipeline by Stage of Development, 2016 10 Promius Pharma, LLC - Monotherapy Products in Pipeline, 2016 11 Promius Pharma, LLC - Pre-Registration, 2016 12 Promius Pharma, LLC - Phase III, 2016 13 Promius Pharma, LLC - Phase II, 2016 14 Promius Pharma, LLC - Phase I, 2016 15 Promius Pharma, LLC - Preclinical, 2016 16 Promius Pharma, LLC - Pipeline by Target, 2016 40 Promius Pharma, LLC - Pipeline by Route of Administration, 2016 41 Promius Pharma, LLC - Pipeline by Molecule Type, 2016 42 Promius Pharma, LLC - Pipeline Products by Mechanism of Action, 2016 43 Promius Pharma, LLC - Recent Pipeline Updates, 2016 44 Promius Pharma, LLC - Dormant Developmental Projects,2016 45
List of Figures
Promius Pharma, LLC - Pipeline by Indication, 2016 8 Promius Pharma, LLC - Pipeline by Stage of Development, 2016 10 Promius Pharma, LLC - Monotherapy Products in Pipeline, 2016 11 Promius Pharma, LLC - Pipeline by Target, 2016 40 Promius Pharma, LLC - Pipeline by Route of Administration, 2016 41 Promius Pharma, LLC - Pipeline by Molecule Type, 2016 42 Promius Pharma, LLC - Pipeline Products by Mechanism of Action, 2016 43
Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected toRead More...
Europe industrial air filtration market size is projected to reach USD 1,690.8 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing implementation in various industries such as metal, cement and food & beverages among otRead More...
Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to drivRead More...
Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from mainRead More...
Global gas sensors market is expected to reach USD 2,512.4 million by 2020, as per a new research report by Radiant Insights, Inc. High adoption rate of wireless and smart gas sensor technology coupled with escalating demand from end-use industries sRead More...
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.